Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.
about
Transarterial radioembolization for hepatocellular carcinoma: a reviewCT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive ReviewSide effects of yttrium-90 radioembolizationTransarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developmentsYttrium-90 radioembolization of liver tumors: what do the images tell us?Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.Radioembolization of hepatic lesions from a radiobiology and dosimetric perspectiveRadioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectivesTransarterial radioembolization for hepatocellular carcinoma: An update and perspectivesPlanning Arteriography for Yttrium-90 Microsphere RadioembolizationGuidelines by the AAPM and GEC-ESTRO on the use of innovative brachytherapy devices and applications: Report of Task Group 167.Treatment of primary liver tumors with Yttrium-90 microspheres (TheraSphere) in high risk patients: analysis of survival and toxicities.Temporary arterial balloon occlusion as an adjunct to Yttrium-90 radioembolization.Agreement between competing imaging measures of response of hepatocellular carcinoma to yttrium-90 radioembolization.Selective internal radiation therapy with SIR-Spheres in hepatocellular carcinoma and cholangiocarcinoma.Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model.Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods.Pilot study of angiogenic response to yttrium-90 radioembolization with resin microspheresCoordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of diseaseRadioembolization for the treatment of hepatocellular carcinomaRadiation therapy for liver tumors: ready for inclusion in guidelines?Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection.Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis.High lung shunt fraction in colorectal liver tumors is associated with distant metastasis and decreased survival.Selective internal radiation therapy of hepatic tumors: procedural implications of a patent hepatic falciform arteryTreatment planning and volumetric response assessment for Yttrium-90 radioembolization: semiautomated determination of liver volume and volume of tumor necrosis in patients with hepatic malignancy.Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlationImaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma.Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.Research reporting standards for radioembolization of hepatic malignancies.Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times.Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma.Radioembolization for hepatocellular carcinoma complicated by biliary stricture.Multimodal treatment of unresectable hepatocellular carcinoma to achieve complete response results in improved survival.A single-center experience in radioembolization as salvage therapy of hepatic metastases of uveal melanoma.Radioembolization for primary and metastatic liver cancer.Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experienceRadioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomesExtrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients.
P2860
Q26738273-8F35F94C-F165-4A79-B236-D64DEA10CEEFQ26770014-93A3BFBC-6E3B-400E-A2F8-0B38478B9255Q26821887-E0EED7C6-CF59-4E5B-BF0F-56809FF94A0FQ26852174-12055C20-C82A-46ED-90A9-A706E6BE18D8Q26997064-B640D67C-4B28-4056-B4B1-8FBBA8C7E46DQ26998606-B8E15C73-484E-492F-98BE-945C40CC6074Q26998661-6A87F978-CAA8-4171-A4C2-B16B5DCAA507Q27023616-336FE4C1-E14F-40DC-9927-80214F1B8216Q28081783-E34EB946-3E82-4E9C-AC53-A866CEF4ADB5Q28081878-9C2C6D10-3EF6-44E6-8688-355952E8CB23Q30151984-85ECC532-9045-44B4-8C26-B85AC4ADA75DQ30447735-CACDE285-D1D7-48A2-BC75-81C210878331Q30456316-1BCDC554-A79F-4577-82F8-53BBC0F06FB8Q33532957-D9395B5A-8FF6-47A9-B7CF-3D186C926411Q33593257-D7D55ABB-0FAE-4DE9-ADB3-E0B3BEC70B9BQ33691454-7237B76F-40D3-4E7F-A36F-F7A675E12783Q33715683-1AFE3ADB-3158-4ED9-A298-FFAB935F1CB8Q33768719-FFE6C0DA-B453-4C13-9074-932F1620ED1EQ33867596-9C65DC83-DFB6-4A3A-BA2F-1EC023CE4F82Q33870879-E4619D64-1B99-4D6A-A2F4-90E6E9CB119FQ33872976-FC43636A-44B6-4AD6-9968-5146ACC029ECQ34005194-5B974330-E01C-4F3F-AC5D-FB79D9B74D44Q34077181-3F2930D3-52A8-4916-8F8C-99259062465FQ34155198-4CBF88AA-2345-41F7-BA75-BE876B24808AQ34254640-35672098-B256-4CDF-BDB0-7B087A0A9368Q34339718-50F05D2F-B518-493C-AAFD-F3BC0774C52DQ34681148-3E69B675-6059-42D5-A8B1-9CD9AE46C604Q34982068-A94F8FE4-9494-4026-9574-BE85ED7E0FBEQ35051942-B4D87315-0791-4B36-9141-C10DE9E37493Q35085486-204680D3-1AD3-456B-A0F9-B548C6826937Q35111887-B20DFDD4-20E9-4918-9262-BF301C8B2442Q35154103-2E07D245-4477-4761-A42D-07BDF48D5970Q35164855-9438A2FA-0FFE-42F7-97E5-82AC797F5E8FQ35347127-952DFF96-53EE-4E82-BE34-C6E30172D50CQ35469188-3557A5E9-21B6-4534-9F22-69FC91CCCC1EQ35528970-147BEB76-1A3A-4487-91AB-F7B0528448E8Q35564038-2BC2F761-4F68-4342-85C4-9ADFF41308FDQ35687650-EF0CE844-7D4C-40B5-BE7A-8A84947498FDQ35815482-34ACE247-3AE6-4B8F-B969-8FC1F221CD32Q35877902-9469660E-16B5-4DB0-A38C-338BF48606FD
P2860
Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Radioembolization with 90Yttri ...... d methodologic considerations.
@ast
Radioembolization with 90Yttri ...... d methodologic considerations.
@en
type
label
Radioembolization with 90Yttri ...... d methodologic considerations.
@ast
Radioembolization with 90Yttri ...... d methodologic considerations.
@en
prefLabel
Radioembolization with 90Yttri ...... d methodologic considerations.
@ast
Radioembolization with 90Yttri ...... d methodologic considerations.
@en
P1476
Radioembolization with 90Yttri ...... nd methodologic considerations
@en
P2093
Kenneth G Thurston
P304
P356
10.1097/01.RVI.0000233785.75257.9A
P50
P577
2006-08-01T00:00:00Z